Therapeutic Drug Monitoring of Rivastigmine and Donepezil Under Consideration of CYP2D6 Genotype-Dependent Metabolism of Donepezil

Therapeutic Drug Monitoring of Rivastigmine and Donepezil Under Consideration of CYP2D6 Genotype-Dependent Metabolism of Donepezil

Marion Ortner,1 Marion Stange,1 Heike Schneider,1 Charlotte Schröder,2 Katharina Buerger,3 Claudia Müller,3 Felix Müller-Sarnowski,1 Janine Diehl-Schmid,1 Hans Förstl,1 Timo Grimmer1 ,* Werner Steimer2, * 1Department of Psychiatry and Psychotherapy, Technical Univ...

Full description

Bibliographic Details
Main Authors: Ortner M, Stange M, Schneider H, Schröder C, Buerger K, Müller C, Müller-Sarnowski F, Diehl-Schmid J, Förstl H, Grimmer T, Steimer W
Format: Article
Language:English
Published: Dove Medical Press 2020-08-01
Series:Drug Design, Development and Therapy
Subjects:
alzheimer’s disease
cytochrome p-450 enzymes
genetic polymorphism
therapeutic drug monitoring
mass spectrometry
Online Access:https://www.dovepress.com/therapeutic-drug-monitoring-of-rivastigmine-and-donepezil-under-consid-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/therapeutic-drug-monitoring-of-rivastigmine-and-donepezil-under-consid-peer-reviewed-article-DDDT

Similar Items